Variables | Control group | Intervention group | ||||||
---|---|---|---|---|---|---|---|---|
 | 2021 | 2022 | 2021 | 2022 | ||||
 | No. of patients with a chronic prescription | No. of patients with a low-value chronic prescription | No. of patients with a chronic prescription | No. of patients with a low-value chronic prescription | No. of patients with a chronic prescription | No. of patients with a low-value chronic prescription | No. of patients with a chronic prescription | No. of patients with a low-value chronic prescription |
No. of patients with a chronic ARMs prescription | 1,982 | 996 (50.3%) | 1,894 | 942 (49.7%) | 1,733 | 889 (51.3%) | 1,694 | 899 (53.1%) |
% female | 54.1% | 54.6% | 53.3% | 54.8% | 62.2% | 54.7% | 54.8% | 56.1% |
No. of patients per age category | Â | |||||||
 0–49 | 229 | 225 | 229 | 227 | 155 | 152 | 165 | 163 |
 50–59 | 299 | 291 | 258 | 255 | 275 | 271 | 270 | 266 |
 60–69 | 456 | 328 | 438 | 302 | 452 | 333 | 435 | 326 |
 70–79 | 555 | 152 | 560 | 158 | 487 | 133 | 492 | 144 |
 80 + | 443 | 0 | 409 | 0 | 364 | 0 | 332 | 0 |
No. of patients per SES category | Â | |||||||
 Lowest | 359 | 178 | 315 | 164 | 587 | 335 | 545 | 324 |
 Below average | 269 | 139 | 545 | 241 | 319 | 158 | 298 | 160 |
 Average | 678 | 327 | 392 | 183 | 146 | 93 | 131 | 77 |
 Above average | 339 | 158 | 294 | 142 | 601 | 266 | 636 | 298 |
 Highest | 337 | 194 | 348 | 212 | 80 | 37 | 84 | 40 |